Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 350 points on Tuesday.
The Dow traded down 0.93% to 37,243.85 while the NASDAQ fell 0.58% to 14,885.45. The S&P 500 also fell, dropping, 0.66% to 4,752.36.
U.S. stocks traded mostly lower midway through trading, with the Dow Jones index falling more than 150 points on Tuesday.
The Dow traded down 0.46% to 37,421.80 while the NASDAQ fell 0.02% to 14,969.24. The S&P 500 also fell, dropping, 0.17% to 4,775.50.
Allakos reports disappointing topline data from phase 2 trials for lirentelimab in atopic dermatitis and chronic spontaneous urticaria. Company undergoes restructuring to focus on AK006, extending cash runway into mid-2026.
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 200 points on Tuesday.
Following the market opening Tuesday, the Dow traded down 0.56% to 37,384.20 while the NASDAQ fell 0.69% to 14,869.02. The S&P 500 also fell, dropping, 0.53% to 4,758.60.